Barely Significant
← all phrases

“a numerical trend”

1,013 sentences · 1,013 papers · 1,817 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

Although this difference was modest, it indicates a numerical trend toward shorter PACU stay among patients treated with acetaminophen; however, the difference was not statistically significant and should not be interpreted as evidence of clinically meaningful improvement in postoperative recovery efficiency.
Although increasing uncontrolled risk factor burden was associated with a numerical trend toward higher AF recurrence, this did not reach statistical significance; this may reflect limited power, and the finding should be interpreted as hypothesis-generating rather than evidence of no clinically relevant gradient.
No single findings in the clinical assessment were able to differentiate between pSpA and non-SpA, but there was a numerical trend towards lower scores in patients’ global assessment in patients with pSpA (5.6±1.6) versus non-SpA (6.5±2.5), which was similar also in the physicians’ global assessment ( table 1 ).
PFS was descriptively analyzed in prespecified subgroups and findings were generally consistent with the main analysis conducted in the intention-to-treat population ( Fig 2B ); however, there was a numerical trend that favored treatment with T-DM1 for patients who had received previous neoadjuvant or adjuvant therapy with trastuzumab or lapatinib (prior treatment: HR, 0.75 [97.5% CI, 0.52 to 1.09]; no prior treatment: HR, 1.12 [97.5% CI, 0.82 to 1.54]) and for patients who had received prior taxane (prior taxane: HR, 0.69 [97.5% CI, 0.48 to 0.99]; no prior taxane: HR, 1.10 [97.5% CI, 0.85 to 1.41]).
Hazard ratio was calculated for risk of obtaining a non-diagnostic sample Results SS mean cellularity 45.7% SD 25.7 FS mean cellularity 72.9% SD 17.0 Difference in mean cellularity 27.2% two-tailed p-value=.08 Hazard ratio of obtaining a non-diagnostic sample with SS: HR 5 p=0.28 No statistically significant difference in results but a numerical trend is noted.
61 Nonetheless, a numerical trend in favour of combination therapy was noted, which the authors suggested might have clinical value in selected high-risk patients with residual disease activity despite bDMARD therapy.
Year in Review: Axial Spondyloarthritis.
Mediterr J Rheumatol · 2026 · PMC12835917